Rigaud C, Abbou S, Ducassou S, Simonin M, Le Mouel L, Pereira V, Gourdon S, Lambilliotte A, Geoerger B, Minard-Colin V, Brugieres L. Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement. haematol [Internet]. 2022Sep.1 [cited 2024Nov.24];107(9):2255-60. Available from: https://haematologica.org/article/view/haematol.2021.280081